The use of SGLT-2 inhibitors produces cardiovascular benefits and reduces the risk of progression of renal impairment in patients with T2DM.Â
Read More »What does Resistant Hypertension Mean for Diabetes Patients?
Can a diagnosis of resistant hypertension give clinicians a clue on what patients can expect for their future?
Read More »Prevalence of Unrecognized Myocardial Infarction in Asymptomatic Patients With Diabetes
Can using DE-MRI image scans determine the prevalence of unrecognized MIs in asymptomatic patients with diabetes?
Read More »Benefits of Pioglitazone Plus Insulin For Type 2
Combination dual therapy reduces mortality by 50%.
Read More »First Major Breakthrough In 20 Years For The Treatment of Diabetic Kidney Disease and Heart Failure
FDA has approved a new treatment for diabetic kidney disease, which affects one in three patients with type 2 diabetes.
Read More »Coronary Artery Calcification and Cardiovascular Disease in Patients with Type 1 Diabetes
Is the CAC score a reliable tool in assessing cardio risk in patients with type 1 diabetes?
Read More »New Diabetes Medications Have Reduced Heart Failure Risk by 34 Percent
Study examines SGLT-2 inhibitors versus DPP-4 in reducing cardiovascular events.
Read More »Depression + Diabetes = Increased Risk for Cardiovascular Outcomes
Patients who have diabetes should be screened for psychological risk factors.
Read More »Decreased eGFR and Increased Albuminuria Highly Predictive of Major Clinical Outcomes in T2DM Patients
Combined analysis of eGFR and albuminuria over 2 years has been shown to predict T2DM patients’ risk for major macrovascular outcomes.
Read More »Childhood Cardiovascular Risk Factors Can Predict Adult-Onset Diabetes
While cardiovascular risk factors are used to predict risk for clinical outcomes and base therapies, it may be a fluctuation in such risk factor measurements that has the most impact.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.